New #Stocks in Biotech
(Nasdaq: $TELA) Cannabis (CSE: $HFH.C), Crypto (CSE: $LNK.C) and eSports (CSE:
$NWES.C) at Investor Ideas
Point Roberts WA, Delta BC, November 22, 2019 –
(Investorideas.com Newswire) Investorideas.com, a global news source and
leading investor resource announces its weekly roundup of stocks added to its global stock
directories in biotech, cannabis, China-Asia, crypto and eSports.
This week’s new biotech companies include multiple
Nasdaq IPO’s which are involved in biopharmaceuticals, medical technology and
biotechnologies.
The newest cannabis companies are both listed on
Canadian Exchanges (TSXV & CSE) and are involved in CBD products, including
pharmaceutical cannabidiol.
The latest China-Asia companies are also Nasdaq
IPO’s and cross over into the tech, cloud, Health and Wellness and real estate
sectors.
The newest crypto company is the Canadian Stock
Exchange listed Link Global Technologies Inc. (CSE: LNK) which provides infrastructure
and operating expertise for cryptocurrency mining and blockchain technologies,
while the latest eSports company is also CSE listed and provides capital
and support services to esports organizations, teams, leagues, events,
platforms, tools, and technology innovators.
New Biotech Companies
TELA Bio,
Inc. (NasdaqGM:TELA) is a commercial stage medical technology company
focused on designing, developing and marketing a new category of tissue
reinforcement materials to address unmet needs in soft tissue reconstruction.
TELA’s products are designed to improve on shortcomings of existing biologics
and minimize long-term exposure to permanent synthetic material. TELA's
portfolio is supported by quality, data-driven science and extensive
pre-clinical research that has consistently demonstrated advantages over other
commercially available products.
Centogene
N.V. (NasdaqGM:CNTG) is a commercial-stage company focused on rare
diseases that transforms real-world clinical and genetic data into actionable
information for patients, physicians and pharmaceutical companies. The
Company’s goal is to bring rationality to treatment decisions and to accelerate
the development of new orphan drugs by using our knowledge of the global rare
disease market, including epidemiological and clinical data and innovative
biomarkers. Centogene has developed a global proprietary rare disease platform
based on our real-world data repository with over 2.0 billion weighted data
points from over 450,000 patients representing 115 different countries as of
August 31, 2019, or an average of over 500 data points per patient. The
Company’s platform includes epidemiologic, phenotypic and genetic data that
reflects a global population, and also a biobank of these patients’ blood
samples. Centogene believes this represents the only platform that
comprehensively analyzes multi-level data to improve the understanding of rare
hereditary diseases, which can aid in the identification of patients and
improve our pharmaceutical partners’ ability to bring orphan drugs to the
market. As of August 31, 2019, the Company collaborated with over 35
pharmaceutical partners for over 30 different rare diseases
Galera
Therapeutics, Inc. (NasdaqGM:GRTX) is a clinical-stage biopharmaceutical company
focused on developing and commercializing a pipeline of novel, proprietary
therapeutics that have the potential to transform radiotherapy in cancer.
Galera’s lead product candidate is GC4419 (avasopasem manganese), a highly
selective and potent small molecule dismutase mimetic that is designed to
rapidly convert superoxide to hydrogen peroxide. GC4419 is being studied in the
Phase 3 ROMAN trial for its ability to reduce the duration, incidence and
severity of radiation-induced severe oral mucositis in patients with locally
advanced head and neck cancer, its lead indication. The FDA granted Fast Track
and Breakthrough Therapy designations to GC4419 for the reduction of the
duration, incidence and severity of severe oral mucositis induced by
radiotherapy. Galera is headquartered in Malvern, PA.
CNS Pharmaceuticals,
Inc. (NasdaqCM:CNSP) is a pre-clinical stage biotechnology company
specializing in the development of novel treatments for primary and metastatic
brain and central nervous system tumors. Its lead candidate Berubicin is for
the treatment of glioblastoma, a type of brain cancer currently considered
incurable, as well as pancreatic and ovarian cancers, and lymphonas. The
Company entered into an IP agreement with Houston Pharmaceuticals, Inc. and a
Purchase Agreement with Reata Pharmaceuticals Inc.
Iovance Biotherapeutics,
Inc.(NasdaqGS: IOVA) intends to improve patient care by
making T cell-based immunotherapies broadly accessible for the treatment of
patients with solid tumors and blood cancers. Tumor infiltrating lymphocyte
(TIL) therapy uses a patient’s own immune cells to attack cancer. TIL cells are
extracted from a patient’s own tumor tissue, expanded through a proprietary
process, and infused back into the patient. After infusion, TIL reach tumor
tissue, where they attack tumor cells. The company is currently conducting
pivotal studies in patients with metastatic melanoma and advanced cervical
cancer. In addition, the company’s TIL therapies are being investigated for the
treatment of patients with locally advanced, recurrent or metastatic cancers
including head and neck and non-small cell lung cancer. Clinical studies of T
cell therapy for blood cancers called peripheral blood lymphocyte (PBL) therapy
are being planned.
New Cannabis Companies:
Cardiol
Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) is focused on producing pharmaceutical
cannabidiol (CBD) products and developing innovative therapies for heart
disease, including acute myocarditis and other causes of heart failure. The
Company's lead product, CardiolRx™, is designed to be one of the safest and
most consistent CBD formulations on the market. CardiolRx is pharmaceutically
produced, cGMP certified, and is THC free. The Company plans to commercialize
CardiolRx in the billion-dollar market for medicinal cannabinoids in Canada and
is also pursuing distribution opportunities in Europe and Latin America. In
heart failure, Cardiol is planning an international clinical study of CardiolRx
in acute myocarditis, a condition caused by inflammation in heart tissue, which
remains the most common cause of sudden cardiac death in people less than 35
years of age. The Company is also developing proprietary nanotechnology to
uniquely deliver pharmaceutical CBD and other anti-inflammatory drugs directly
to sites of inflammation in the heart that are associated with heart failure.
Heart failure is the leading cause of death and hospitalization in North
America with associated healthcare costs in the U.S. alone exceeding $30
billion
Hemp for Health Inc. (CSE:HFH) is a cultivator and
distributor of premium CBD products. The company has an exclusive, long-term
contract for land with farmers in the Tuscan region of Italy to achieve their
purpose of yielding high quality CBD extracts. The company’s goal is to offer
superior natural and organic CBD products, starting with pristine soil, seeds
and sun.
New China-Asia Companies
ECMOHO Limited (NasdaqGM:MOHO) operates as an integrated solution provider in
the non-medical health and wellness market. The company acts as a bridge
between brand owners and consumers by marketing and distributing health
supplements and food, mother and child care products, personal care products,
household healthcare equipment, and other health and wellness products.
Fangdd Network Group Ltd. (NasdaqGM:DUO)
is a leading property technology company in China. Through innovative use of
mobile internet, cloud and big data, FangDD has fundamentally revolutionized
the way real estate agents conduct business through a suite of modular products
and services powered by technology. FangDD operates China’s largest online real
estate marketplace as measured by the number of registered agents on its
marketplace as of December 31, 2018. Of the approximately 2.0 million real
estate agents in China, more than 911,000 were on its platform as of December
31, 2018, representing a penetration rate of over 45%.
Q&K International Group Limited (NasdaqGM:QK)
is a leading technology-driven long-term apartment rental platform in China.
The Company offers young, emerging urban residents conveniently-located,
ready-to-move-in, and affordable branded apartments as well as facilitates a
variety of value-added services. Qingke signs long-term leases with individual
landlords in different locations in relatively inexpensive yet convenient
locations and manages them centrally, leveraging its advanced IT and mobile
technologies. Technology is at the core of Qingke’s business and is applied to
every step of its operational process from apartment sourcing, renovation, and
tenant acquisition, to property management. The focus on technology enables
Qingke to operate a large, dispersed, and fast-growing portfolio of apartments
with high operational efficiency and deliver a superior user experience.
36Kr Holdings
Inc. (NasdaqGM:KRKR) is a prominent brand and a pioneering platform
dedicated to serving New Economy participants in China with the mission of
empowering New Economy participants to achieve more. The Company started its
business with high-quality New Economy-focused content offerings, covering a
variety of industries in China’s New Economy with diverse distribution
channels. Leveraging traffic brought by high-quality content, the Company has
expanded its offerings to business services, including online advertising
services, enterprise value-added services and subscription services to address
the evolving needs of New Economy companies and upgrading needs of traditional
companies. The Company is supported by comprehensive database and strong data
analytics capabilities. Through diverse service offerings and the significant
brand influence, the Company is well-positioned to continuously capture the
high growth potentials of China’s New Economy.
New Crypto Companies
Link
Global Technologies Inc. (CSE: LNK) is engaged in the business of providing
infrastructure and operating expertise for cryptocurrency mining and blockchain
technology, and of locating and securing, for lease and option to purchase,
properties with access to low-cost reliable power and deploying the low-cost
power to conduct digital mining and to supply energy for other data hosting
services. Link is headquartered in
Vancouver, British Columbia and carries out cryptocurrency mining activities in
Boardman, Oregon, USA and Beaver Falls, British Columbia. It mines cryptocurrency coins with its own
computing power.
New Esports Companies
NEW WAVE ESPORTS CORP. (CSE:NWES) is an esports and
competitive gaming company that provides capital and support services to
esports organizations, teams, leagues, events, platforms, tools, and technology
innovators. New Wave Esports has leadership teams located in Toronto, Ontario
and Los Angeles, California.
The directories are not meant as recommendations
but as a research tool to discover opportunities and trading ideas in a
particular sector.
About Investorideas.com - News
that Inspires Big Investing Ideas Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports
biotech, water, renewable energy and more. Investor Idea’s original branded
content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis
News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining, the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of
third party sourced news, articles and equity research as well as creates
original content, including video, interviews and articles. Original content
created by investorideas is protected by copyright laws other than syndication
rights. Our site does not make recommendations for purchases or sale of stocks,
services or products. Nothing on our sites should be construed as an offer or
solicitation to buy or sell products or securities. All investing involves risk
and possible losses. This site is currently compensated for news publication
and distribution, social media and marketing, content creation and more.
Disclosure is posted for each compensated news release, content published
/created if required but otherwise the news was not compensated for and was
published for the sole interest of our readers and followers. Contact
management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news
services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Learn more about our news, PR and social media
services at Investorideas.com
To sponsor a daily podcast for the month or to be an expert guest please
contact us!
Contact
Investorideas.com
800-665-0411
No comments:
Post a Comment